Therefore, understanding the mechanism governing the role of GSDMD in obesity will assist in understanding low-level adipose tissue inflammation and provide new ideas for developing therapeutics against obesity and related metabolic diseases. This evidence concerns the gene GSDMD and metabolic disease.